{"id":538,"date":"2018-07-04T08:52:34","date_gmt":"2018-07-04T06:52:34","guid":{"rendered":"http:\/\/wp.m2olie.de\/?post_type=publications&#038;p=538"},"modified":"2019-07-16T08:52:50","modified_gmt":"2019-07-16T06:52:50","slug":"design-synthesis-in-vitro-and-initial-in-vivo-evaluation-of-heterobivalent-peptidic-ligands-targeting-both-npyy1-and-grp-receptors-an-improvement-for-breast-cancer-imaging","status":"publish","type":"publications","link":"https:\/\/www.m2olie.de\/en\/publications\/design-synthesis-in-vitro-and-initial-in-vivo-evaluation-of-heterobivalent-peptidic-ligands-targeting-both-npyy1-and-grp-receptors-an-improvement-for-breast-cancer-imaging\/","title":{"rendered":"Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y(1))- and GRP-Receptors-An Improvement for Breast Cancer Imaging?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Vall-Sagarra%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29973529\">Vall-Sagarra A<\/a>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Litau%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29973529\">Litau S<\/a>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Decristoforo%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29973529\">Decristoforo C<\/a>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=W%C3%A4ngler%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29973529\">W\u00e4ngler B<\/a>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Schirrmacher%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29973529\">Schirrmacher R<\/a>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Fricker%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29973529\">Fricker G<\/a>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=W%C3%A4ngler%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29973529\">W\u00e4ngler C<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29973529#\">Pharmaceuticals (Basel).<\/a> 2018 Jul 4;11(3). pii: E65. doi: 10.3390\/ph11030065.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">PMID: 29973529 PMCID: <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6161111\/\">PMC6161111<\/a> DOI: <a href=\"https:\/\/doi.org\/10.3390\/ph11030065\" target=\"_blank\" rel=\"noreferrer noopener\">10.3390\/ph11030065<\/a><\/p>\n","protected":false},"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[],"class_list":["post-538","publications","type-publications","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.m2olie.de\/en\/wp-json\/wp\/v2\/publications\/538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m2olie.de\/en\/wp-json\/wp\/v2\/publications"}],"about":[{"href":"https:\/\/www.m2olie.de\/en\/wp-json\/wp\/v2\/types\/publications"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m2olie.de\/en\/wp-json\/wp\/v2\/comments?post=538"}],"version-history":[{"count":1,"href":"https:\/\/www.m2olie.de\/en\/wp-json\/wp\/v2\/publications\/538\/revisions"}],"predecessor-version":[{"id":539,"href":"https:\/\/www.m2olie.de\/en\/wp-json\/wp\/v2\/publications\/538\/revisions\/539"}],"wp:attachment":[{"href":"https:\/\/www.m2olie.de\/en\/wp-json\/wp\/v2\/media?parent=538"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.m2olie.de\/en\/wp-json\/wp\/v2\/categories?post=538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}